GlassScriptPhysician profile
David M Perelstein
NPI 1548231822
$981.34
in general payments reported to CMS, 2019-2025
12 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $16.95 · 2021: $179 · 2022: $191 · 2023: $165 · 2024: $115 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $159.40 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System, Coblation, Microraptor |
| Paratek Pharmaceuticals, INC. | $141.94 | 2020-2025 | Nuzyra |
| Medtronic, INC. | $132.29 | 2024-2025 | In.Pact Admiral, Venaseal |
| Biotissue Holdings INC. | $126.05 | 2021 | |
| Bone Support INC. | $119.86 | 2022 | |
| Stryker Corporation | $119.22 | 2019-2022 | |
| Acera Surgical, INC. | $53.22 | 2021 | |
| Tactile Systems Technology INC | $37.94 | 2025 | Flexitouch Plus, Nimbl |
| Integra Lifesciences Corporation | $26.97 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Treace Medical Concepts, INC. | $25.44 | 2025 | |
| Averitas Pharma INC. | $20.72 | 2023 | Qutenza |
| Abbott Laboratories | $18.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Perelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.